Vita 34 AG
XETRA:V3V
Vita 34 AG
Current Portion of Long-Term Debt
Vita 34 AG
Current Portion of Long-Term Debt Peer Comparison
Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vita 34 AG
XETRA:V3V
|
Current Portion of Long-Term Debt
€7.8m
|
CAGR 3-Years
56%
|
CAGR 5-Years
28%
|
CAGR 10-Years
49%
|
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
Current Portion of Long-Term Debt
€1.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
21%
|
Fresenius SE & Co KGaA
XETRA:FRE
|
Current Portion of Long-Term Debt
€1.1B
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
0%
|
|
E
|
Euroeyes International Eye Clinic Ltd
HKEX:1846
|
Current Portion of Long-Term Debt
HK$69.8m
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
Synlab AG
XETRA:SYAB
|
Current Portion of Long-Term Debt
€140m
|
CAGR 3-Years
5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vita 34 AG's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
7.8m
EUR
Based on the financial report for Dec 31, 2023, Vita 34 AG's Current Portion of Long-Term Debt amounts to 7.8m EUR.
What is Vita 34 AG's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
49%
Over the last year, the Current Portion of Long-Term Debt growth was -52%. The average annual Current Portion of Long-Term Debt growth rates for Vita 34 AG have been 56% over the past three years , 28% over the past five years , and 49% over the past ten years .